Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean ertugliflozin pivalate and sitagliptin phosphate?
Displaying drugs 12726 - 12750 of 14392 in total

C-CAR039

C-CAR039 is an autologous Chimeric Antigen Receptors (CAR) T-cell therapy expressing CD19/CD20 bi-specific CAR.
Investigational

TTX-MC138

TTX-MC138 is an antisense oligonucleotide targeting miR-10b. It is under investigation for the treatment of various metastatic cancers.
Investigational

CYNK-101

CYNK-101 is an allogeneic human placental hematopoietic stem cell-derived natural killer (NK) cell therapy product that is genetically modified to express a variant of CD16 (CD16VP).
Investigational

CLZ-2002

CLZ-2002 consists of allogeneic mesenchymal stem cells derived neuronal regeneration-promoting cells.
Investigational

MT-401

MT-401 is an allogeneic multi-tumor-associated antigen-specific T-cell therapy.
Investigational

TUM012

TUM012 is a synthetic polymer PEG conjugated to a phospholipid anchor (2-dipalmitoyl-sn-glycerol-3-phosphatidylethanolamine)
Investigational

MBX-2109

MBX-2109 is a long-acting parathyroid hormone peptide prodrug under investigation for the treatment of hyperparathyroidism.
Investigational

HG004

Investigational

BG1805

BG1805 is an investigational anti-CLL1 chimeric antigen receptor (CAR) T-cell therapy.
Investigational

Palopegteriparatide

Palopegteriparatide is a mPEG conjugated parathyroid hormone 1-34.
Investigational

Autologous adipose-derived stromal vascular fraction cells

Investigational

Recombinant human insulin-like growth factor 1

Investigational

Rovaleucel

Rovaleucel is an EBV-specific autologous T-cell therapy under investigation for the treatment of EBV-positive cancers.
Investigational

Metelimumab

Metelimumab (CAT-192) is a monoclonal antibody targeted against transforming growth factor (TGF) beta-1.
Investigational

Certepetide

Investigational

Olezarsen

Olezarsen is an antisense oligonucleotide targeting messenger RNA for apolipoprotein C-III (APOC3).
Investigational

Sulanemadlin

Investigational

LG-100268

LG-100268 is a retinoid X receptor (RXR) selective compound.
Experimental

5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine

Experimental

1h-Benoximidazole-2-Carboxylic Acid

Experimental

7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide

Experimental

2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium

Experimental

4,5,6,7-Tetrachloro-3h-Isobenzofuran-1-One

Experimental

SB220025

Experimental

1-Naphthyl-L-alanine

Experimental
Displaying drugs 12726 - 12750 of 14392 in total